Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Aug 28;329(7464):480.
doi: 10.1136/bmj.38181.482222.55. Epub 2004 Aug 2.

Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis

Djillali Annane  1 , Eric Bellissant, Pierre Edouard Bollaert, Josef Briegel, Didier Keh, Yizhak Kupfer
Affiliations
Review

Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis

Djillali Annane et al. BMJ. .

Abstract

Objective: To assess the effects of corticosteroids on mortality in patients with severe sepsis and septic shock.

Data sources: Randomised and quasi-randomised trials of corticosteroids versus placebo (or supportive treatment alone) retrieved from the Cochrane infectious diseases group's trials register, the Cochrane central register of controlled trials, Medline, Embase, and LILACS.

Review method: Two pairs of reviewers agreed on eligibility of trials. One reviewer entered data on to the computer and four reviewers checked them. We obtained some missing data from authors of trials and assessed methodological quality of trials.

Results: 16/23 trials (n = 2063) were selected. Corticosteroids did not change 28 day mortality (15 trials, n = 2022; relative risk 0.92, 95% confidence interval 0.75 to 1.14) or hospital mortality (13 trials, n = 1418; 0.89, 0.71 to 1.11). There was significant heterogeneity. Subgroup analysis on long courses (> or = 5 days) with low dose (< or = 300 mg hydrocortisone or equivalent) corticosteroids showed no more heterogeneity. The relative risk for mortality was 0.80 at 28 days (five trials, n = 465; 0.67 to 0.95) and 0.83 at hospital discharge (five trials, n = 465, 0.71 to 0.97). Use of corticosteroids reduced mortality in intensive care units (four trials, n = 425, 0.83, 0.70 to 0.97), increased shock reversal at 7 days (four trials, n = 425; 1.60, 1.27 to 2.03) and 28 days (four trials, n = 425, 1.26, 1.04 to 1.52) without inducing side effects.

Conclusions: For all trials, regardless of duration of treatment and dose, use of corticosteroids did not significantly affect mortality. With long courses of low doses of corticosteroids, however, mortality at 28 days and hospital morality was reduced.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Effects of corticosteroids on all cause mortality at 28 days in patients with severe sepsis and septic shock
Fig 2
Fig 2
Effects of corticosteroids on mortality in intensive care unit in patients with severe sepsis and septic shock
Fig 3
Fig 3
Effects of corticosteroids on mortality in hospital in patients with severe sepsis and septic shock
Fig 4
Fig 4
Effects of corticosteroids on shock reversal in patients with severe sepsis and septic shock
Fig 5
Fig 5
Adverse effects of corticosteroids in patients with severe sepsis and septic shock
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Angus D, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29: 1303-10. - PubMed
    1. Rangel-Frausto MS, Pittet D, Hwang T, Woolson RF, Wenzel RP. The dynamics of disease progression in sepsis: Markov modeling describing the natural history and the likely impact of effective antisepsis agents. Clin Infec Dis 1998;27: 185-90. - PubMed
    1. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. Current epidemiology of septic shock: the CUB-Réa Network. Am J Resp Crit Care Med 2003;168: 165-72. - PubMed
    1. Annane D, Cavaillon JM. Corticosteroids in sepsis: from bench to bedside? Shock 2003;20: 197-207. - PubMed
    1. Annane D, Sébille V, Troché G, Raphael JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotrophin. JAMA 2000;283: 1038-45. - PubMed

Substances